Recent Company News

• 07:12 AM ET Dec 15, 2025
  

  RedHill Biopharma announces Opaganib results indicating a reduction in Venetoclax resistant cells ($1.21, 0.00)

• 07:00 AM ET Dec 15, 2025
  

  RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells

• 07:00 AM ET Dec 01, 2025
  

  RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement

• 09:31 AM ET Nov 04, 2025
  

  RedHill Announces $10.5 Million New York Supreme Court Judgment Win Now Final for Enforcement

• 09:33 AM ET Nov 04, 2025
  

  RedHill Biopharma announces $10.5M NY supreme court judgment win against Kukbo ($1.54, +0.27)

• 09:04 AM ET Oct 20, 2025
  

  Cumberland (CPIX) to invest $4M for a 30% ownership stake in RedHill's global Talicia business. ($1.50, 0.00)

• 08:07 AM ET Oct 06, 2025
  

  RedHill Biopharma signs new $1.8M plus sales royalties Middle East deal for Talicia - 6-K ($1.90, 0.00)

• 07:05 AM ET Sep 29, 2025
  

  RedHill announces New York Supreme Court upholds company's $10M summary Judgment against Kukbo ($1.84, 0.00)

• 07:04 AM ET Sep 05, 2025
  

  RedHill Biopharma reports H1 gross profit $2.5M vs year-ago $1.2M ($1.23, 0.00)